Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus

Clinical Endocrinology

Volumn 80, Issue 5, 2014, Pages 649-655

  Neumann, Thomas ^a   Hofbauer, Lorenz C ^b   Rauner, Martina ^b   Lodes, Sabine ^a   Kästner, Bettina ^a   Franke, Sybille ^a   Kiehntopf, Michael ^a   Lehmann, Thomas ^a   Müller, Ulrich A ^a   Wolf, Gunter ^a   Hamann, Christine ^c   Sämann, Alexander ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCOSE; HEMOGLOBIN A1C; OSTEOCALCIN; PARATHYROID HORMONE; SCLEROSTIN; VITAMIN D; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; GENETIC MARKER; SOST PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FEMUR NECK; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; GENETIC MARKER; GLOMERULUS FILTRATION RATE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; YOUNG ADULT;

ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 84898547690     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12364     Document Type: Article

References (35)

1. Nicodemus, K.K., &, Folsom, A.R., (2001) Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care, 24, 1192-1197.
2. Masse, P.G., Pacifique, M.B., Tranchant, C.C., et al,. (2010) Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected. Journal of the American College of Nutrition, 29, 419-429.
3. Schwartz, A.V., Sellmeyer, D.E., Ensrud, K.E., et al,. (2001) Older women with diabetes have an increased risk of fracture: a prospective study. Journal of Clinical Endocrinology and Metabolism, 86, 32-38.
4. Neumann, T., Samann, A., Lodes, S., et al,. (2011) Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabetic Medicine, 28, 872-875.
5. Vestergaard, P., (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporosis International, 18, 427-444.
6. Thrailkill, K.M., Liu, L., Wahl, E.C., et al,. (2005) Bone formation is impaired in a model of type 1 diabetes. Diabetes, 54, 2875-2881.
7. Kular, J., Tickner, J., Chim, S.M., et al,. (2012) An overview of the regulation of bone remodelling at the cellular level. Clinical Biochemistry, 45, 863-873.
8. Westendorf, J.J., Kahler, R.A., &, Schroeder, T.M., (2004) Wnt signaling in osteoblasts and bone diseases. Gene, 341, 19-39.
9. Moester, M.J., Papapoulos, S.E., Lowik, C.W., et al,. (2010) Sclerostin: current knowledge and future perspectives. Calcified Tissue International, 87, 99-107.
10. Atkins, G.J., Rowe, P.S., Lim, H.P., et al,. (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. Journal of Bone and Mineral Research, 26, 1425-1436.
11. Mirza, F.S., Padhi, I.D., Raisz, L.G., et al,. (2010) Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 95, 1991-1997.
12. Amrein, K., Amrein, S., Drexler, C., et al,. (2012) Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. Journal of Clinical Endocrinology and Metabolism, 97, 148-154.
13. Brunkow, M.E., Gardner, J.C., Van Ness, J., et al,. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. American Journal of Human Genetics, 68, 577-589.
14. Li, X., Ominsky, M.S., Niu, Q.T., et al,. (2008) Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. Journal of Bone and Mineral Research, 23, 860-869.
15. Modder, U.I., Hoey, K.A., Amin, S., et al,. (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. Journal of Bone and Mineral Research, 26, 373-379.
16. Gaudio, A., Pennisi, P., Bratengeier, C., et al,. (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. Journal of Clinical Endocrinology and Metabolism, 95, 2248-2253.
17. Garcia-Martin, A., Rozas-Moreno, P., Reyes-Garcia, R., et al,. (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 97, 234-241.
18. Gennari, L., Merlotti, D., Valenti, R., et al,. (2012) Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 97, 1737-1744.
19. Ainsworth, B.E., Haskell, W.L., Leon, A.S., et al,. (1993) Compendium of physical activities: classification of energy costs of human physical activities. Medicine and Science in Sports and Exercise, 25, 71-80.
20. Clevers, H., &, Nusse, R., (2012) Wnt/beta-catenin signaling and disease. Cell, 149, 1192-1205.
21. Rachner, T.D., Khosla, S., &, Hofbauer, L.C., (2011) Osteoporosis: now and the future. Lancet, 377, 1276-1287.
22. Glass, D.A. 2nd, Bialek, P., Ahn, J.D., et al,. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental Cell, 8, 751-764.
23. Nakashima, T., Hayashi, M., Fukunaga, T., et al,. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nature Medicine, 17, 1231-1234.
24. Loots, G.G., Kneissel, M., Keller, H., et al,. (2005) Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Research, 15, 928-935.
25. Thorson, S., Prasad, T., Sheu, Y., et al,. (2013) Sclerostin and bone strength in women in their 10 decade of life. Journal of Bone and Mineral Research, 28, 2008-2016.
26. Confavreux, C.B., (2011) Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney International Supplement, 121, S14-S19.
27. Hamann, C., Rauner, M., Hohna, Y., et al,. (2013) Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. Journal of Bone and Mineral Research, 28, 627-638.
28. O'Brien, C.A., Plotkin, L.I., Galli, C., et al,. (2008) Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One, 3, e2942.
29. Gaudio, A., Privitera, F., Battaglia, K., et al,. (2012) Sclerostin levels associated with inhibition of the Wnt/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 97, 3744-3750.
30. Bonewald, L.F., (2011) The amazing osteocyte. Journal of Bone and Mineral Research, 26, 229-238.
31. Ardawi, M.S., Rouzi, A.A., &, Qari, M.H., (2012) Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study. Journal of Clinical Endocrinology and Metabolism, 97, 3691-3699.
32. Spatz, J.M., Fields, E.E., Yu, E.W., et al,. (2012) Serum sclerostin increases in healthy adult men during bed rest. Journal of Clinical Endocrinology and Metabolism, 97, E1736-E1740.
33. Robling, A.G., Niziolek, P.J., Baldridge, L.A., et al,. (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. Journal of Biological Chemistry, 283, 5866-5875.
34. Armamento-Villareal, R., Sadler, C., Napoli, N., et al,. (2012) Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. Journal of Bone and Mineral Research, 27, 1215-1221.
35. van Oers, R.F., van Rietbergen, B., Ito, K., et al,. (2011) A sclerostin-based theory for strain-induced bone formation. Biomechanics and Modeling in Mechanobiology, 10, 663-670.